Welcome to our dedicated page for ASTERA LABS SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Latency budgets, chiplet yields, and hyperscaler design wins crowd Astera Labs� SEC disclosures. If parsing a semiconductor 10-K feels like decoding SerDes eye diagrams, you’re not alone. Stock Titan’s AI pinpoints what matters—so you can stop sifting through tables and start understanding how every PCIe /CXL milestone moves ALAB.
Need the Astera Labs quarterly earnings report 10-Q filing? It’s here the moment it hits EDGAR, paired with an AI-powered summary that turns margin shifts and substrate constraints into plain English. Watching executive behavior? Get Astera Labs Form 4 insider transactions in real time and track option exercises alongside upcoming tape-outs.
Our coverage spans every form:
- Astera Labs annual report 10-K simplified—see reliance on a handful of foundry partners and key cloud customers.
- Astera Labs proxy statement executive compensation—compare R&D incentives to peers.
- Astera Labs 8-K material events explained—from sudden supply-chain updates to new chip qualification wins.
- Astera Labs insider trading Form 4 transactions—filter by director, grant type, or sale price.
Every filing includes AI-generated highlights, red-flag alerts, and direct links to line-item references—perfect for analysts asking, “How do I read Astera Labs� 10-K?� or retail investors searching, “Astera Labs SEC filings explained simply.� Save hours modeling revenue sensitivity, monitor Astera Labs earnings report filing analysis, and make informed calls with data distilled the moment it’s disclosed.
Astera Labs, Inc. (ALAB) filed a Form 144 notifying a proposed sale of 100,000 common shares with an aggregate market value of $19,118,990. The shares are to be sold on NASDAQ around 08/12/2025 through Morgan Stanley Smith Barney LLC. The filing lists 166,219,140 shares outstanding, so the proposed sale equals approximately 0.06% of outstanding shares.
The securities were acquired as founder stock on 09/11/2020. The filing also discloses recent sales by TATE 1997 LIVING TRUST: three tranches on 08/07/2025 totaling 100,000 shares for combined gross proceeds of $17,138,480.00, and a 05/30/2025 sale of 500,000 shares for $45,098,194.00. The filer attests they do not know any undisclosed material adverse information.
Astera Labs director Stefan A. Dyckerhoff reported multiple sales of company common stock on 08/07/2025 and 08/08/2025 totaling 52,000 shares. The filings show weighted-average sale prices in ranges reported between $172.50 and $175.86. Following the reported transactions one line reports direct beneficial ownership of 74,154 shares and the filing discloses substantial indirect holdings, including 364,064 shares held by a trust and several ~3,765-share holdings by named entities. The form notes 2,351 shares to be issued upon vesting of restricted stock units and includes standard disclaimers that certain partnership and trust holdings are disclaimed except for pecuniary interest. The Form 4 is signed and dated 08/11/2025.
Mohan Jitendra, Chief Executive Officer and director of Astera Labs (ALAB), reported sales of company common stock on 08/07/2025 executed under a Rule 10b5-1 trading plan adopted December 2, 2024. The Form 4 discloses a weighted average sale price of $170.3278 and lists lot-level price ranges and quantities for the transactions in a detailed footnote.
The filing also discloses amounts held indirectly by trusts: a Living Trust with 4,280,002 shares; a Trust with 699,999 shares; 2021 Trusts 1 and 2 with 700,000 shares each; and 2022 Trusts 1 and 2 with 450,001 shares each. The reporting person disclaims beneficial ownership of those trust holdings except to the extent of any pecuniary interest.
Michael Truett Tate, Chief Financial Officer of Astera Labs, reported multiple transactions in the issuer's common stock on August 7�8, 2025. The filing discloses a total of 278,373 shares sold across several block transactions with reported weighted-average prices of $169.608, $170.3396, $171.4778 and $173.8234, and price ranges noted between $169.05 and $174.04. The report also records bona fide gifts of 7,500 shares to the GlobalStar DAF and 10,000 shares to a non-affiliated person.
The filing shows indirect ownership through the Tate 1997 Living Trust and GlobalStar DAF and disclaims direct beneficial ownership beyond any pecuniary interest. Following the reported transactions, the Tate Trust's reported indirect holdings are shown as 501,496 shares. Footnotes state the seller will provide details on the number of shares sold at each separate price upon request.
Gajendra Sanjay, President and COO of Astera Labs (ALAB), reported automated sales under a Rule 10b5-1 plan adopted November 30, 2024. On 08/07/2025 he sold a total of 280,000 shares in multiple transactions at prices ranging approximately from $165.17 to $175.00. Following the sales, the filing shows Trust 1 holds 5,525,545 shares, Trust 2 and Trust 3 each hold 695,000 shares, and the reporting person directly holds 2,262,318 shares. The filing disclaims beneficial ownership of the trust-held shares except for any pecuniary interest, and the reporting person offers to provide transaction-level price details on request.
Astera Labs' Form 144 discloses a proposed sale of 26,000 common shares on NASDAQ through broker Stifel, with an aggregate market value of $4,556,737.00 and the issuer reported 162,150,000 shares outstanding. The filing shows the shares were acquired in private placements: 1,000 on 05/17/2022 and 25,000 on 11/08/2019. A related sale by Stefan A Dyckerhoff of 26,000 shares on 08/07/2025 for $4,508,959.00 is also listed. The notice includes the seller's representation that they do not possess undisclosed material adverse information and contains the standard legal warning about intentional misstatements.
FAQ
What is the current stock price of ASTERA LABS (ALAB)?
What is the market cap of ASTERA LABS (ALAB)?
